Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of metformin in refractory hidradenitis suppurativa
2016-002714-45Phase 3Active
- Sponsor
- Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of metformin in hidradenitis suppurativa (HS), sponsored by Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz. Primary endpoint: Change in Sartorius score at 24 weeks. Started Nov 2016; status: active.
02
Drugs
metformin
03
Conditions
hidradenitis suppurativa (HS)
Beyond the preview
Go deeper on 2016-002714-45.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002714-45.